Keyphrases
Respiratory Syncytial Virus Infection
100%
Respiratory Syncytial Virus
100%
Th-2
100%
Interleukin-4 (IL-4)
50%
Virus-specific
33%
Interferon-α (IFN-α)
33%
Cellular Immune Response
16%
Viral Infection
16%
B Cells
16%
Cell Culture
16%
Peripheral Blood Mononuclear Cells
16%
Serum IgE
16%
Immunopathogenesis
16%
Antibody Response
16%
Cytotoxic T Cells
16%
Supernatant
16%
CD8+ T Cells
16%
Interferon Production
16%
Healthy Controls
16%
IgE Antibody
16%
CD8+
16%
Activation Markers
16%
Pokeweed Mitogen
16%
Th-1
16%
Hospitalised Infants
16%
CD25+
16%
Acute Lower Respiratory Infection
16%
Lymphocyte Phenotype
16%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
100%
Interleukin 4
50%
Interferon Type I
33%
B Cell
16%
Lymphocyte
16%
Cytokine
16%
Immunoglobulin E
16%
Virus
16%
Age
16%
Viral Disease
16%
Phenotype
16%
CD8
16%
Peripheral Blood Mononuclear Cell
16%
Adoptive Immunity
16%
Immunopathogenesis
16%
Antibody Response
16%
Cytotoxic T-Cell
16%
Cytotoxic T Cell
16%
Interferon Production
16%
Supernatant
16%
Immunoglobulin E Antibody
16%
CD25
16%
Pokeweed Mitogen
16%
INIS
viruses
100%
infants
100%
production
33%
control
33%
interleukins
33%
interferon
33%
comparative evaluations
22%
hypothesis
11%
antibodies
11%
lymphocytes
11%
blood
11%
cytokines
11%
mitogens
11%
phenotype
11%
Neuroscience
Immunoglobulin E Antibody
33%